FNDC5 and cartilage disease: In conclusion, our findings demonstrate that irisin is involved in cartilage development and OA pathogenesis, and that the aberrant alteration of irisin expression in OA cartilage may imply that irisin could be a promising therapeutic target for treating bone and cartilage disorders including OA and rheumatoid arthritis (RA).